Massimo Palmarini

SARS-CoV-2 variants evolve convergent strategies to remodel the host response

Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses

International Pediatric COVID-19 Severity Over the Course of the Pandemic

Delayed Mucosal Antiviral Responses Despite Robust Peripheral Inflammation in Fatal COVID-19

Scientific Business Abstracts

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19

A prenylated dsRNA sensor protects against severe COVID-19

Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination

Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK

Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England

TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction

Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland

“Ménage à Trois”: The Evolutionary Interplay between JSRV, enJSRVs and Domestic Sheep

Drosophila melanogaster as a Model Organism for Bluetongue Virus Replication and Tropism